封面
市場調查報告書
商品編碼
2126462

檢體管理市場:策略洞察與預測(2026-2031 年)

Specimen Management Market - Strategic Insights and Forecasts (2026-2031)

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 175 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計檢體管理市場將從 2026 年的 37.8 億美元成長到 2031 年的 96.4 億美元,複合年成長率為 11.0%。

全球檢體管理市場正經歷強勁成長,這主要得益於精準醫療和分子診斷的普及以及生物銀行活動的擴展。檢體管理涵蓋技術、耗材、軟體和服務,使檢查室能夠處理生物檢體的整個生命週期,包括採集、標記、運輸、儲存、監測和搜尋。該市場的目標客戶包括醫院、診斷檢查室、製藥公司、生物技術公司、合約研究組織 (CRO)、生物樣本庫和學術研究機構,在這些機構中,檢體品質決定了下游分析結果的可靠性。分子診斷、基因組檢測和個人化醫療計畫的日益普及,推動了對標準化檢體工作流程的需求不斷成長。這是因為,隨著檢體庫存規模和複雜性的增加,持續的可追溯性和受控的儲存環境變得至關重要。監管機構持續強調檢體完整性、文件準確性和資料可追溯性,鼓勵檢查室以自動化檢體管理平台取代人工流程。這種變革在提高營運效率的同時,也為可重複的研究、法規遵循和高品質的患者照護提供了支持。

市場促進因素

精準醫療與分子診斷的廣泛應用

  • 精準醫療依賴從採集到檢查室分析全程保持完整性的準確生物檢體。可靠的生物數據對於個人化治療決策至關重要,促使醫療機構拓展基因組檢測、伴隨診斷和分子病理學服務。隨著檢測日益複雜,對標準化檢體處理和貫穿整個檢測流程的持續追蹤的需求也日益成長。製造商正在開發整合的檢體管理平台,將自動化識別、儲存和追溯功能融為一體。這種轉變推動了臨床診斷和研究領域對先進檢體管理解決方案的需求。

擴大生物銀行和臨床研究活動

  • 生物樣本庫透過保存生物檢體以供長期科學研究,為生物醫學研究提供支援。轉化醫學、人群健康研究和再生醫學領域對大規模生物樣本庫的需求日益成長,推動了研究機構檢體收集量的增加。不斷成長的檢體庫存給人工儲存和搜尋系統帶來了營運負擔,同時也增加了文件記錄的要求。技術供應商正在擴展自動化生物樣本庫管理系統,以提高儲存效率和檢體可追溯性。這些趨勢正在推動對先進檢體管理基礎設施的持續需求。

檢查室自動化技術的進步

  • 檢查室自動化透過減少整個檢體處理流程中的人工操作來提高效率。隨著檢體量的增加以及對更快出具結果且不影響品質的需求日益成長,診斷檢查室正在採用機器人檢體處理系統。人工檢體處理有誤判、污染和流程延誤等風險。供應商正在將自動化檢體運輸、儲存和追蹤技術與檢查室資訊系統整合,以簡化操作。自動化在提高檢查室生產力的同時,也能確保檢體在整個檢測生命週期中的完整性。

監理機關越來越重視檢體的可追溯性

  • 醫療和實驗室機構在法規環境下運作,檢體可追溯性直接影響品質保證和病人安全。由於生物檢體支持診斷和治療決策,監管機構不斷加強對記錄儲存歷史、標準化標籤和檢驗儲存條件的要求。人工記錄限制了審計能力,並增加了合規風險。實驗室正在實施數位化檢體管理系統,以提供電子記錄、審計追蹤和即時庫存監控。因此,合規性仍然是市場擴張的關鍵驅動力。

市場限制因素

  • 自動化儲存系統、整合軟體平台和檢查室基礎設施升級的高昂實施成本仍然限制了小規模檢查室採用這些系統。將檢體管理平台與傳統實驗室資訊系統和現有分析儀器整合在技術上仍然十分複雜,延長了實施週期。資料安全、系統驗證和合規性要求仍然是採用雲端檢體管理解決方案的檢查室面臨的營運挑戰。

目錄

第1章執行摘要

  • 市場概述
  • 主要發現
  • 分析師意見
  • 策略建議

第2章:調查方法

  • 調查設計
  • 資料收集和調查方法
  • 市場規模估算
  • 預測模型
  • 先決條件和限制

第3章:檢體管理市場:概述、市場規模與預測

  • 市場定義和範圍
  • 行業概覽
  • 產業變化
  • 主要市場趨勢
  • 市場規模表現分析
  • 市場預測
  • 測試檢體工作流程概述
  • 檢體可追溯性與儲存歷史分析
  • 生物銀行和生物樣本管理的發展趨勢
  • 檢查室自動化實施現況分析
  • 數檢體生命週期管理

第4章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰

第5章 行業情勢

  • 產業價值鏈分析
  • 定價分析
  • 實驗室工作流程最佳化分析
  • 生物銀行和臨床研究的生態系統分析

第6章:創新趨勢

  • 新興技術
  • 產品創新
  • 人工智慧在檢體管理的應用
  • 實驗室自動化和機器人整合
  • 基於RFID和條碼的追蹤技術
  • 基於雲端的檢體管理解決方案

第7章 監理情勢

  • 法律規範
  • 檢體處理及儲存標準
  • 合規要求

第8章:檢體管理市場:展望分析

  • 分析:依產品類型
  • 分析:按技術
  • 分析:透過應用
  • 分析:按最終用戶
  • 分析:按工作流程階段

第9章:檢體管理市場:細分市場分析

  • 依產品類型
    • 檢體採集工具包
    • 檢體運輸系統
    • 檢體儲存系統
    • 檢體追蹤系統
    • 檢體管理軟體
    • 耗材和配件
  • 透過技術
    • 條碼追蹤
    • 基於RFID的追蹤
    • 與實驗室資訊管理系統(LIMS)整合
    • 自動化檢體處理系統
    • 基於雲端的檢體管理平台
  • 透過使用
    • 臨床診斷
    • 生物銀行
    • 藥物發現與開發
    • 臨床試驗
    • 基因組學與精準醫學
    • 病理檢查室
    • 出於學術和研究目的
  • 最終用戶
    • 醫院和醫療保健系統
    • 臨床診斷檢查室
    • 製藥和生物技術公司
    • 受託研究機構(CRO)
    • 生物樣本庫
    • 學術研究機構

第10章:檢體管理市場:區域分析

  • 北美洲
  • 歐洲
  • 亞太地區
  • 南美洲
  • 中東和非洲

第11章:檢體管理市場:國家分析

  • 美國
  • 加拿大
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
  • 瑞士
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 巴西
  • 沙烏地阿拉伯
  • 南非

第12章 競爭格局

  • 市佔率分析
  • 策略趨勢
  • 併購、合作與聯盟
  • 新產品發布

第13章:公司簡介

  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson and Company(BD)
  • QIAGEN NV
  • Azenta Life Sciences
  • Hamilton Company
  • Tecan Group Ltd.
  • Brooks Automation(Azenta)
  • Avantor, Inc.
  • Corning Incorporated
  • Greiner Bio-One International GmbH
  • TrakCel Ltd.
  • LabVantage Solutions, Inc.
  • LabWare Inc.
  • Ziath Ltd.
  • SPT Labtech Ltd.

第14章:檢體管理市場:商業預測分析

第15章:投資與資金籌措分析

  • 創業投資趨勢
  • 政府為生物銀行和實驗室基礎設施提供資金
  • 研發投資

第16章:未來展望

  • 主要成長機遇
  • 未來產業趨勢
簡介目錄
Product Code: KSI-009140

The Specimen Management Market is forecast to grow at a CAGR of 11.0%, reaching USD 9.64 billion in 2031 from USD 3.78 billion in 2026.

The global specimen management market is experiencing robust growth, driven by the increasing adoption of precision medicine, molecular diagnostics, and the expansion of biobanking activities. Specimen management encompasses technologies, consumables, software, and services that enable laboratories to collect, label, transport, store, monitor, and retrieve biological samples throughout their lifecycle. The market serves hospitals, diagnostic laboratories, pharmaceutical companies, biotechnology firms, contract research organizations, biobanks, and academic research institutions where specimen quality determines the reliability of downstream analytical results. Increasing molecular diagnostics, genomic testing, and personalized medicine programs are expanding demand for standardized specimen workflows because larger and more complex sample inventories require continuous traceability and controlled storage environments. Regulatory agencies continue emphasizing sample integrity, documentation accuracy, and data traceability, encouraging laboratories to replace manual processes with automated specimen management platforms. This evolution strengthens operational efficiency while supporting reproducible research, regulatory compliance, and high-quality patient care.

Market Drivers

Increasing Adoption of Precision Medicine and Molecular Diagnostics

  • Precision medicine depends on accurate biological specimens that maintain integrity from collection through laboratory analysis. Healthcare providers are expanding genomic testing, companion diagnostics, and molecular pathology services because individualized treatment decisions require reliable biological data. Higher testing complexity increases the need for standardized specimen handling and continuous tracking throughout laboratory workflows. Manufacturers are developing integrated specimen management platforms that combine automated identification, storage, and traceability capabilities. This transition strengthens demand for advanced specimen management solutions across clinical diagnostics and research environments.

Expansion of Biobanking and Clinical Research Activities

  • Biobanks support biomedical research by preserving biological specimens for long-term scientific investigation. Research organizations are increasing specimen collection because translational medicine, population health studies, and regenerative medicine require extensive biological repositories. Larger specimen inventories create operational pressure on manual storage and retrieval systems while increasing documentation requirements. Technology providers are expanding automated biobank management systems that improve storage efficiency and sample traceability. These developments reinforce sustained demand for advanced specimen management infrastructure.

Growing Laboratory Automation

  • Laboratory automation improves efficiency by reducing manual intervention across specimen processing workflows. Diagnostic laboratories are implementing robotic handling systems because increasing sample volumes require faster turnaround without compromising quality. Manual specimen handling introduces risks related to misidentification, contamination, and workflow delays. Vendors are integrating automated specimen transport, storage, and tracking technologies with laboratory information systems to streamline operations. Automation strengthens laboratory productivity while improving specimen integrity throughout the testing lifecycle.

Increasing Regulatory Focus on Sample Traceability

  • Healthcare and research laboratories operate within regulated environments where specimen traceability directly influences quality assurance and patient safety. Regulatory authorities continue strengthening expectations for documented chain of custody, standardized labeling, and validated storage conditions because biological specimens support diagnostic and therapeutic decision-making. Manual documentation limits audit readiness and increases compliance risks. Laboratories are adopting digital specimen management systems that provide electronic records, audit trails, and real-time inventory monitoring. Regulatory compliance therefore remains a significant driver of market expansion.

Market Restraints

  • High implementation costs associated with automated storage systems, integrated software platforms, and laboratory infrastructure upgrades continue limiting adoption among smaller laboratories. Integration of specimen management platforms with legacy laboratory information systems and existing analytical equipment remains technically complex, increasing implementation timelines. Data security, system validation, and compliance requirements continue creating operational challenges for laboratories deploying cloud-based specimen management solutions.

Technology and Segment Insights

By Product Type

  • Specimen collection kits form the foundation of specimen management because the quality of downstream laboratory analysis depends on proper sample collection and preservation. Healthcare providers are increasing adoption of standardized collection kits as molecular diagnostics and genomic analysis expand. Specimen transport systems ensure sample integrity during transit between collection sites and laboratories. Specimen storage systems, including refrigerators, freezers, and automated storage units, maintain sample viability for future testing. Specimen tracking systems and management software provide digital visibility and chain-of-custody documentation. Consumables and accessories support routine specimen handling operations.

By Technology

  • Barcode technology remains the most widely adopted specimen tracking solution because it provides reliable identification while maintaining cost-effective implementation. RFID-based tracking offers enhanced automation and real-time visibility for high-value specimens. Laboratory Information Management System (LIMS) integration enables seamless data flow between specimen management and laboratory workflows. Automated specimen handling systems, including robotic storage and retrieval, improve efficiency in high-volume laboratories. Cloud-based specimen management platforms are gaining adoption for multi-site laboratory networks requiring centralized visibility and standardized workflows.

By Application

  • Clinical diagnostics represents the largest application segment because accurate specimen management directly influences patient diagnosis and treatment decisions. Hospitals and diagnostic laboratories are processing increasing numbers of biological specimens as chronic diseases and molecular testing continue expanding. Biobanking is a significant and growing application, supporting long-term storage for research. Drug discovery and development, clinical trials, genomics and precision medicine, pathology laboratories, and academic research studies represent additional applications driving demand for specialized specimen management solutions.

By End User

  • Hospitals and health systems represent a major end-user segment, managing large volumes of clinical specimens. Clinical diagnostic laboratories require standardized specimen workflows for routine and specialized testing. Pharmaceutical and biotechnology companies utilize specimen management for drug development and research. Contract Research Organizations (CROs) need efficient specimen logistics for clinical trials. Biobanks require long-term storage and tracking solutions. Academic and research institutes utilize specimen management for various scientific investigations.

Competitive and Strategic Outlook

  • The competitive landscape features major laboratory suppliers and specialized specimen management providers. Thermo Fisher Scientific Inc. distinguishes itself through its comprehensive laboratory workflow portfolio, combining specimen collection products, cold storage systems, automation, and informatics. Becton, Dickinson and Company (BD) differentiates itself through global leadership in specimen collection devices and preanalytical solutions. QIAGEN N.V. specializes in sample technologies supporting molecular diagnostics and genomics. Azenta Life Sciences maintains a strong position through specialized expertise in automated biobanking and biological sample storage. Hamilton Company and Tecan Group Ltd. provide advanced laboratory automation technologies. Greiner Bio-One International GmbH offers a strong portfolio of specimen collection products and consumables. LabVantage Solutions, Inc. provides enterprise laboratory informatics integrating specimen management.
  • Strategic developments include increasing integration of artificial intelligence and digital tracking, expansion of automated biobanking infrastructure, and development of cloud-connected laboratory ecosystems. Companies are forming partnerships to enhance interoperability between specimen management platforms and other laboratory systems. Product launches focus on automated storage solutions, RFID tracking systems, and integrated software platforms. Companies that successfully combine automated hardware, intelligent software, and regulatory expertise are expected to maintain competitive leadership.

Conclusion

  • The specimen management market is poised for significant growth, driven by the increasing adoption of precision medicine, expansion of biobanking, and laboratory automation. The evolution from standalone storage solutions toward integrated digital ecosystems supporting the entire specimen lifecycle is reshaping the market. Companies that successfully deliver automated, traceable, and compliant specimen management solutions are expected to lead the market. Ongoing technological innovation, regulatory support, and expanding research infrastructure across emerging economies will further accelerate adoption throughout the forecast period.

Key Benefits of this Report

  • Insightful Analysis: Detailed market insights across regions, customer segments, policies, socio-economic factors, consumer preferences, and industry verticals.
  • Competitive Landscape: Understand strategic moves by key players to identify optimal market entry approaches.
  • Market Drivers and Future Trends: Assess major growth forces and emerging developments shaping the market.
  • Actionable Recommendations: Support strategic decisions to unlock new revenue streams.
  • Caters to a Wide Audience: Suitable for startups, research institutions, consultants, SMEs, and large enterprises.

What Businesses Use Our Reports For

  • Industry and market insights, opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, and competitive intelligence.

Report Coverage

  • Historical data from 2021 to 2024, Base year 2025, and Forecast years from 2026 to 2031
  • Growth opportunities, challenges, supply chain outlook, regulatory framework, and trend analysis
  • Competitive positioning, strategies, and market share evaluation, and trade analysis
  • Revenue growth and forecast assessment across segments and regions
  • Company profiling including strategies, products, financials, and key developments

TABLE OF CONTENTS

1. Executive Summary

  • 1.1 Market Snapshot
  • 1.2 Key Findings
  • 1.3 Analyst Insights
  • 1.4 Strategic Recommendations

2. Research Methodology

  • 2.1 Research Design
  • 2.2 Data Collection Methodology
  • 2.3 Market Size Estimation
  • 2.4 Forecasting Model
  • 2.5 Assumptions & Limitations

3. Specimen Management Market Overview, Size & Forecast

  • 3.1 Market Definition & Scope
  • 3.2 Industry Overview
  • 3.3 Industry Evolution
  • 3.4 Key Market Trends
  • 3.5 Historical Market Size Analysis (2021-2025)
  • 3.6 Market Forecast (2026-2031)
  • 3.7 Laboratory Specimen Workflow Overview
  • 3.8 Sample Traceability & Chain of Custody Analysis
  • 3.9 Biobanking & Biospecimen Management Trends
  • 3.10 Laboratory Automation Adoption Analysis
  • 3.11 Digital Specimen Lifecycle Management

4. Market Dynamics

  • 4.1 Market Drivers
  • 4.2 Market Restraints
  • 4.3 Market Opportunities
  • 4.4 Market Challenges

5. Industry Landscape

  • 5.1 Industry Value Chain Analysis
  • 5.2 Pricing Analysis
  • 5.3 Laboratory Workflow Optimization Analysis
  • 5.4 Biobanking & Clinical Research Ecosystem Analysis

6. Innovation Landscape

  • 6.1 Emerging Technologies
  • 6.2 Product Innovation
  • 6.3 AI Integration in Specimen Management
  • 6.4 Laboratory Automation & Robotics Integration
  • 6.5 RFID & Barcode-Based Tracking Technologies
  • 6.6 Cloud-Based Specimen Management Solutions

7. Regulatory Landscape

  • 7.1 Regulatory Framework
  • 7.2 Sample Handling & Storage Standards
  • 7.3 Compliance Requirements

8. Specimen Management Market Landscape Analysis

  • 8.1 Analysis by Product Type
  • 8.2 Analysis by Technology
  • 8.3 Analysis by Application
  • 8.4 Analysis by End User
  • 8.5 Analysis by Workflow Stage

9. Specimen Management Market Segment Analysis (2021-2031)

  • 9.1 By Product Type
    • 9.1.1 Specimen Collection Kits
    • 9.1.2 Specimen Transport Systems
    • 9.1.3 Specimen Storage Systems
    • 9.1.4 Specimen Tracking Systems
    • 9.1.5 Specimen Management Software
    • 9.1.6 Consumables & Accessories
  • 9.2 By Technology
    • 9.2.1 Barcode-Based Tracking
    • 9.2.2 RFID-Based Tracking
    • 9.2.3 Laboratory Information Management System (LIMS) Integration
    • 9.2.4 Automated Specimen Handling Systems
    • 9.2.5 Cloud-Based Specimen Management Platforms
  • 9.3 By Application
    • 9.3.1 Clinical Diagnostics
    • 9.3.2 Biobanking
    • 9.3.3 Drug Discovery & Development
    • 9.3.4 Clinical Trials
    • 9.3.5 Genomics & Precision Medicine
    • 9.3.6 Pathology Laboratories
    • 9.3.7 Academic & Research Studies
  • 9.4 By End User
    • 9.4.1 Hospitals & Health Systems
    • 9.4.2 Clinical Diagnostic Laboratories
    • 9.4.3 Pharmaceutical & Biotechnology Companies
    • 9.4.4 Contract Research Organizations (CROs)
    • 9.4.5 Biobanks
    • 9.4.6 Academic & Research Institutes

10. Specimen Management Market Geographical Analysis (2021-2031)

  • 10.1 North America
  • 10.2 Europe
  • 10.3 Asia-Pacific
  • 10.4 South America
  • 10.5 Middle East & Africa

11. Specimen Management Market Country Analysis (2021-2031)

  • 11.1 United States
  • 11.2 Canada
  • 11.3 Germany
  • 11.4 United Kingdom
  • 11.5 France
  • 11.6 Italy
  • 11.7 Spain
  • 11.8 Netherlands
  • 11.9 Switzerland
  • 11.10 China
  • 11.11 Japan
  • 11.12 India
  • 11.13 South Korea
  • 11.14 Australia
  • 11.15 Brazil
  • 11.16 Saudi Arabia
  • 11.17 South Africa

12. Competitive Landscape

  • 12.1 Market Share Analysis
  • 12.2 Strategic Developments
  • 12.3 Mergers & Acquisitions, Partnerships & Collaborations
  • 12.4 Product Launches

13. Company Profiles

  • 13.1 Thermo Fisher Scientific Inc.
  • 13.2 Becton, Dickinson and Company (BD)
  • 13.3 QIAGEN N.V.
  • 13.4 Azenta Life Sciences
  • 13.5 Hamilton Company
  • 13.6 Tecan Group Ltd.
  • 13.7 Brooks Automation (Azenta)
  • 13.8 Avantor, Inc.
  • 13.9 Corning Incorporated
  • 13.10 Greiner Bio-One International GmbH
  • 13.11 TrakCel Ltd.
  • 13.12 LabVantage Solutions, Inc.
  • 13.13 LabWare Inc.
  • 13.14 Ziath Ltd.
  • 13.15 SPT Labtech Ltd.

14. Specimen Management Market Commercial Forecast Analysis

  • 14.1 Specimen Collection Systems
  • 14.2 Automated Specimen Storage Systems
  • 14.3 Specimen Tracking Solutions
  • 14.4 Biobank Specimen Management Platforms
  • 14.5 Clinical Trial Specimen Management Solutions
  • 14.6 Integrated LIMS-Based Specimen Management Systems
  • 14.7 AI-Enabled Specimen Workflow Solutions

15. Investment & Funding Analysis

  • 15.1 Venture Capital Trends
  • 15.2 Government Funding for Biobanking & Laboratory Infrastructure
  • 15.3 R&D Investments

16. Future Outlook

  • 16.1 Key Growth Opportunities
  • 16.2 Future Industry Trends